Top Markets
#1 MowCat MowCat +803.98%
#2 龙虾 (Lobster) 龙虾 (Lobster) +74.88%
#3 SODAX SODAX +46.96%
#4 Cortex Cortex +28.92%
#5 Magma Finance Magma Finance +18.49%
#6 Akedo Akedo +18.20%
#7 OpenEden OpenEden +17.56%
#8 BNB Attestation Service BNB Attestation Service +13.02%
#9 MANTRA MANTRA +12.47%
#10 APEX APEX +12.10%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Rank in Stocks #7327
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Share Price
$36.51
Last synced: 2026-08-27
Market Cap
$1.62B
Change (1 day)
-1.43%
Change (1 year)
-
Country
US
Trade Avalyn Pharma Inc. Common Stock (AVLN)

Category

Healthcare
Number of shares outstanding for Avalyn Pharma Inc. Common Stock (AVLN)
Number of shares outstanding as of August 2026: 0
According to Avalyn Pharma Inc. Common Stock latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Avalyn Pharma Inc. Common Stock (AVLN) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH